Review of HIV-Related Cytopathology by Lang, Tee U. et al.
SAGE-HindawiAccess to Research
Pathology Research International
Volume 2011, Article ID 256083, 12 pages
doi:10.4061/2011/256083
Review Article
Review of HIV-Related Cytopathology
Tee U. Lang,1 Walid E.Khalbuss,1 SaraE.Monaco,1 PamMichelow,2 and LironPantanowitz1
1Department of Pathology, University of Pittsburgh Medical Center Cancer Pavilion, 5150 Centre Avenue, Suite 201, Pittsburgh,
PA 15232, USA
2CytologyUnit, Department of Anatomical Pathology,Faculty of HealthSciences,University of theWitwatersrand and National Health
Laboratory Service, Johannesburg 2192, South Africa
Correspondence should be addressed to Liron Pantanowitz, pantanowitzl@upmc.edu
Received 14 December 2010; Accepted 15 February 2011
Academic Editor: Antonino Carbone
Copyright © 2011 Tee U. Lang et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Exfoliative and aspiration cytologies play a major role in the management of patients with human immunodeﬁciency virus
infection. Common cytology samples include cervicovaginal and anal Papanicolaou tests, ﬁne needle aspirations, respiratory
specimens, body ﬂuids, Tzanck preparations, and touch preparations from brain specimens. While the cytopathologists need
to be aware of speciﬁc infections and neoplasms likely to be encountered in this setting, they should be aware of the current
shift in the pattern of human immunodeﬁciency virus-related diseases, as human immunodeﬁciency virus patients are living
longer with highly active antiretroviral therapy and suﬀering fewer opportunistic infections with better antimicrobialprophylaxis.
There is a rise in nonhuman immunodeﬁciency virus-deﬁning cancers (e.g., anal cancer, Hodgkin’s lymphoma) and entities (e.g.,
gynecomastia) from drug-related side eﬀects. Given that ﬁne needle aspirationis a valuable, noninvasive,and cost-eﬀective tool, it
isfrequentlyemployedintheevaluationanddiagnosisofhumanimmunodeﬁciencyvirus-related diseases.AnalPapanicolaoutests
are also increasing as a result of enhanced screening of human immunodeﬁciency virus-positive patients for cancer. This paper
covers the broad spectrum of diseaseentities likely to be encountered with human immunodeﬁciencyvirus-related cytopathology.
1.Introduction
The current human immunodeﬁciency virus (HIV) pan-
demic has changed considerably, as infected people are now
living longer with chronic HIV infection due to highly active
antiretroviral therapy (HAART). With HAART therapy, the
major cause of death in the later stage of acquired immune
deﬁciency syndrome (AIDS) is malignancy, rather than
infection. Moreover, the spectrum of malignancies encoun-
tered in HIV-positive patients has expanded to include
both AIDS-deﬁning cancers, such as cervical cancer, Kaposi
sarcoma (KS),and non-Hodgkin’slymphoma(NHL),aswell
as non-AIDS-deﬁning cancers (NADC), such as Hodgkin’s
lymphoma, anal cancer, lung carcinoma, and nonmelan-
otic skin cancer [1]. However, individuals unlikely to be
on HAART therapy are still presented with opportunistic
infections, such as tuberculosis, fungi, and parasites. HIV-
infected patients have disproportionately high rates of infec-
tion with oncogenic viruses, such as human papillomavirus
(HPV), Kaposi sarcoma human virus/human herpesvirus-8
(KSHV/HHV-8), and Epstein-Barr virus (EBV). HPV is
closely linked to anogenital cancer [2–4] and HHV-8 as-
sociated malignancies include KS [5], primary eﬀusion lym-
phoma (PEL) [6], and multicentric Castleman’s disease
[7]. Finally, EBV infection has been linked to Hodgkin’s
lymphoma [8], plasmablastic lymphoma (PBL) [9], and
leiomyosarcoma [10].
Both exfoliative and aspiration cytologies play a major
role in the management of patients with HIV. Fine needle
aspiration (FNA) using needles of variable sizes can be
used for diagnostic purposes as well as a therapeutic
modality, as in draining cystic lesions or eﬀusions. FNA has
gained much popularity in evaluating mass lesions in HIV-
positive patients because it is noninvasive, well-tolerated,
inexpensive, and avoids the necessity of subjecting patients
to invasive and costly surgical excision [11]. In addition,
an adequate FNA can usually provide suﬃcient material
for ancillary studies, such as microbiology culture, ﬂow
cytometry, and/or a cell block for immunocytochemical
stains. Anal Pap tests have now been employed at several
centers to screen both men and women for possible anal
cancer [12]. In some circumstances, cytology samples alone2 Pathology Research International
may not always be suitable. For example, the diagnosis of
Castleman’s disease may prove challenging by FNA alone.
In such cases as in lymphadenopathy and bone and soft
tissue lesions, a concomitant needle biopsy is recommended
if resources permit. Another limitation is that FNA may not
exclude all coexisting pathologies (e.g., a lymph node with
lymphoma and Kaposi sarcoma). Figure 1 is a schematic
of the proposed role of cytology in the work-up of an
HIV-positive patient. Cytopathologists will encounter HIV
cytopathic eﬀects, ﬁndings resulting from opportunistic
infection, and/or morphology of neoplasia. This review
covers all aspects of HIV-related cytopathology.
2.HIV CytopathicEffect
HIV may induce a viral cytopathic eﬀect on host cells [13].
This cytopathiceﬀectwas initially observed in vitro by inves-
tigators studying HIV-infected lymphocyte cultures [14].
Soon thereafter, researchers identiﬁed such viral particles in
vivo, while studying HIV-infected human brain [15]a n d
follicular dendritic cells in the lymphoid tissue [16, 17].
HIV causes two types of cytopathic eﬀects: (i) single cell
undergoing irreversible cell membrane ballooning, rupture,
and lysis [13], and (ii) multinucleated giant cells formation
via cell fusion involving the uninfected CD4 molecule [18].
The ability to lyse CD4 T cells contributes to the clinical
condition AIDS. In cytology samples, multinucleated giant
cells in lymphoid tissue resembling Warthin-Finkeldey cells
are often evident in FNA of HIV-associated benign lym-
phoepithelial cyst-like lesions of the parotid gland [19].
The giant cells die soon after they are formed, further
contributing to the depletion of CD4 T cells [18].
3.CervicalNeoplasia
Women infected with HIV have a high prevalence of
HPV infection [20] and, therefore, are at increase risk of
developing uterine cervical cancer [21, 22]. This can be
explained by persistent HPV infection in HIV-seropositive
women with multiple HPV subtypes, particularly high-risk
HPVtypes[23,24].Dependinguponthepopulationstudied,
squamous intraepithelial lesion (SIL) is up to 40-fold higher
inHIV-infectedwomen[25],andupto20%oftheseinfected
women are likely to develop cervical SIL within 3 years
o ft h e i rH I Vd i a g n o s i s[ 26, 27]. Other studies have shown
increased progression rates of low-grade SIL (LSIL) to high-
grade SIL (HSIL) in HIV-positive women [28], and a relative
risk of 5.4 for developing invasive squamous cell cancer
(SCC) [3].
Cervical screening programs attempt to reduce the risk
of cervical cancer by detecting early precursor lesion. A
retrospective study by Maiman [25] demonstrated a higher
rate of abnormal Pap test ﬁndings among HIV-positive
women, reporting abnormalities in as high as 30–60% of
Pap tests and evidence of dysplasia in 15–40% of Pap tests.
The majority of these abnormal Pap tests are due to atypical
squamous cells of unknown signiﬁcance (ASC-US), found
typically in women with a CD4 count <200 cells/mm3 [29].
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Figure 1: Proposed algorithm for the use of cytopathology in
patients with HIV infection.
The rate of abnormal Pap test is also higher in younger
age groups for both LSIL and HSIL [30, 31]. Some studies
have reported that Pap tests in the HIV population are not
reliable in that they have high false-negative rates [27, 32].
However, not all studies support this ﬁnding [33]. Moreover,
some studies have found lower sensitivity and speciﬁcity
of HPV testing in HIV women compared to the general
population[34]. This is not surprising given that many HIV-
positive women are already HPV-positive, particularly with
high risk HPV subtypes [35]. Hence, HPV testing may not
be suitable in this population due to the high prevalence of
HPV, including multiple types.
The combination of high false negative Pap tests and
aggressive cervical disease progression have prompted new
screening guidelines in HIV-positive women. Current guide-
lines from the Centers for disease control (CDC), American
College of Obstetricians and Gynecologists (ACOG) and
American Cancer Society (ACS) recommend annual Pap
tests after initial HIV diagnosis, with an additional six month
screen in the ﬁrst year [36–38]. The CDC also recommends
routine colposcopic screening in view of the high false
negative Pap test in this setting. This recommendation is
supportedbytheBritishSocietyforColposcopyand Cervical
Screening (BSCCS)guideline that advise all newly diagnosed
HIV-positive women to have annual Pap and colposcopy
tests [39]. However, alternate guidelines to perform routine
colposcopy in all newly diagnosed HIV-positive women
are required that are applicable to resource poor countries
[34].
Current data suggests HAART has not signiﬁcantly
altered the rate of HIV-related cervical cancer [40]. However,
there is some convincing evidence that the eﬀect of HAART
on cervical cancer may be most beneﬁcial among women
with early-stage HIV disease [4].RecentFDA-approvedHPV
vaccination against low- and high-risk HPV has shown
eﬃcacy against persistent HPV infection. It remains to be
seen whether early administration of the HPV vaccination
will reduce the burden of HIV-related cervical neoplasia. The
impactofvaccinationmaybelimitedinHIV-positivewomen
due to the high diversity of oncogenic HPV seen in this
population [41].Pathology Research International 3
 
(a) (b)
Figure2:AnalPaptestshowing(a)atrophozoiteofEntamoebahistolytica(arrow,intermediatemagniﬁcation)with(b)ingestederythrocytes
(ThinPrep, Pap stain, high magniﬁcation).
Figure 3: FNA of Kaposi sarcoma showing crowded spindled
lesions with a bloody background (Pap stain, high magniﬁcation).
4.Anal Neoplasia
The incidenceof anal cancerhas gradually increased overthe
last decade, notably in men who have sex with men [42]. In
the USA, 2010 cancer statistics expect 5,260 new diagnoses
and 720 deaths due to anal cancer [43]. Similar to cervical
cancer, anal cancer is mainly associated with high-risk HPV
infection acquiredbyHIV-positive individualswith lowCD4
counts of <500/mm3 [44]. Although not widely established,
screening with anal Pap tests has been shown to be a cost-
eﬀective screening method for the detection of SIL in HIV-
infected patients [45]. The sensitivity of anal cytology to
identify anal squamous lesions ranges between 69–93%[46],
but it suﬀers from reported low speciﬁcity (32–59%) [47].
Moreover, there appears to be poor correlation between
cytology-histology ﬁndings in these anal Pap tests [46].
Unlike cervical cancer, HPV testing of anal cytology samples
has shown poor positive predictive value for high-grade anal
intraepithelial neoplasia (AIN) [47], and it is recommended
that all HIV patients with abnormal anal Pap tests (i.e., with
a diagnosis of ASCUS and above) should undergo high-
resolution anoscopy (HRA)with biopsy to detect high-grade
AIN. Controversial issues concerning anal Pap screening
that remain to be adequately addressed include screening
frequency, timing to intervene with premalignant lesions,
and algorithms for the management of anal Pap test results
[48]. When interpreting anal Pap tests, cytopathologists
should attempt to adhere to the 2001 Bethesda System
utilized for reporting of cervical Pap tests [49]. A satisfactory
anal-rectal specimen should have adequate cellularity with
both nucleated squamous cells and rectal columnar cells.
Other objects, such as obscuring fecal matter, herpes simplex
virus infection and Candida spp., and unusual parasitic
infections [50]( F i g u r e2) can be identiﬁed on anal cytol-
ogy.
5.Skinand SoftTissuePathology
As many as 90% of HIV-positive patients may develop one
or more skin diseases during the course of their illness [51].
The spectrum of skin diseases encompasses noninfective and
infective dermatoses, adverse drug reactions, and dermato-
logic neoplasms. Kaposi sarcoma (KS) is the most common
AIDS-deﬁning cancer, which may involve both cutaneous
and extracutaneous body sites. While most clinicians today
perform biopsies for KS, FNA has previously been shown
to be useful in the diagnosis of KS [52, 53]. Key cytologic
features of KS (Figure 3) include cohesive clusters of spindle4 Pathology Research International
Figure 4: Merkel cell carcinoma cells in a cell block preparation are
immunoreactiveforMerkel cell polyomavirus(CM2B4immunocy-
tochemical stain, high magniﬁcation).
cells, a bloody background, and positive immunostaining
of lesional cells with vascular (CD34) and lymphatic (D2-
40) endothelium markers and/or the HHV-8 antibody latent
nuclear antigen-1 (LNA-1). Although the demonstration
of HHV-8 DNA by molecular techniques proves to be
a useful adjunct in the diagnosis of aspirated KS [5],
contamination of samples by mononuclear hematopoietic
cells that harbor HHV-8 is possible and can be a misleading
ﬁnding.
TheincidenceofskincancersotherthanKS,suchasSCC,
basal cell carcinoma, and Merkel cell carcinoma (MCC), is
increasing in HIV-positive patients [54, 55]. Dermatologic
HPV infection in the HIV population can manifest as
both anogenital lesions (e.g., condyloma acuminata and
intraepithelial neoplasia) and nongenital skin diseases, such
as epidermodysplasia verruciformis [56]. In addition, HIV-
positive patients are predisposed to B-cell cutaneous lym-
phomas, often with an immunoblastic or centroblastic
phenotype and CD30+ EBV+ immunophenotype [57]. HIV
patients with these skin cancers tend to present at a
younger age, manifest with multiple synchronous tumors,
higher recurrence rate, treatment-associated complications,
and a poorer prognosis compared to their HIV-negative
counterparts [54]. MCC was recently shown to harbor a
novel polyomavirus, Merkel cell polyomavirus (MCPyV),
in the majority of cases [58, 59]. MCPyV can be detected
in MCC using polymerase chain reaction (PCR) and the
CM2B4 immunohistochemical stain (Figure 4).
Other rare soft tissue proliferations to be considered in
the HIV-positive patient are mycobacterial pseudotumors
and smooth muscle neoplasms. First described by Wood
et al. [60], mycobacterial pseudotumors predominantly
involve the lymph nodes. They are frequently associated
with atypicalmycobacteria, especially Mycobacteriumavium
intracellulare [61]. Therefore, for any spindle cell lesion in
the setting of HIV infection, it is important to order an acid
fast stain to see if these S100- and CD68-positive spindle
cells contain mycobacterial organisms. A high incidence of
EBV-related smooth muscle neoplasms including leiomy-
omas and leiomyosarcomas has been reported in various
anatomic sites (mainly central nervous system, but also the
gastrointestinal tract, liver, spleen,lung,adrenal, and skin)in
HIV-infected adults and children [62, 63]. Detection of EBV
(e.g., EBER in situ hybridization) along with smooth muscle
markers (e.g., smooth muscle actin) may be of diagnostic
aid.
6.Hematolymphoid Pathology
A large proportion of HIV-infected patients present with
lymphadenopathy that is readily amenable to FNA. The
etiologies diﬀer by geographic region. In Western coun-
tries, such as the USA and England, reactive follicular
hyperplasia is more common than infection or lymphoma
[64–66] whereas infections, such as tuberculosis, prevail
in developing countries [67, 68]. The cytomorphologic
ﬁndings in reactive lymph node ranging from prominent
follicular hyperplasia (specimens have abundant polymor-
phouslymphocytes and tingible-body macrophages) to aspi-
rates derived from advanced-stage lymphadenopathy with
involuted follicles (specimens are lymphoid depleted and
rich in plasma cells). With the latter ﬁndings, Castleman’s
disease should be included in the diﬀerential diagnosis,
and the invariably increasing branching hyaline capillary
fragments should at least raise this diagnostic possibility.
Although atypical follicular dendritic cells are thought to
be diagnostic of Castleman’s disease [7], they are not
consistently found on FNA of lymph node [69]. Therefore,
FNA is not recommended for the diagnosis of Castleman’s
disease [69], and a deﬁnite diagnosis will require biopsy, tis-
sue examination, and immunophenotyping. Mycobacterial
infection is a common infectious cause of lymphadenopathy
in the HIV patient [64]. The cytologic ﬁndings of tuber-
culosis lymphadenitis may be granulomatous, necrotizing,
or suppurative. The diagnosis can be conﬁrmed by the
demonstration of acid fast mycobacteria. In previously
treated patients, culture of aspirated material may yield
negative results, and PCR ampliﬁcation may assist in such
cases. Other rare infectious causes of HIV lymphadenopathy
that can be diagnosed by FNA include pneumocystis [70],
histoplasmosis [71], cryptococcus [72, 73]( F i g u r e5), and
leishmaniasis [74].
The incidence of both Hodgkin and non-Hodgkin’s
lymphoma (NHL) is increasing in the HIV population.
Hodgkin’s lymphoma ranks among the most common
NADC encountered, particularly the mixed cellularity
and lymphocyte-depleted subtypes [75]. In HIV patients,
Hodgkin’s lymphoma may be widely disseminated with
frequent extranodal disease, but rarely mediastinal involve-
ment [76]. Between 75–100% of AIDS-associated Hodgkin’s
lymphoma cases have EBV infection. The diagnosis can
be made by identifying Reed-Sternberg (RS) cells on FNA
smears, along with conﬁrmatory immunostains (e.g., CD30-
and CD15-positive and LCA-negative RS cells). It is alsoPathology Research International 5
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Figure 5: FNA of a neck lymph node cryptococcoma in a 38-year-old HIV-positive man shows multiple encapsulated yeasts (arrows) in
the (a) direct smear (Diﬀ Quick stain, high magniﬁcation) and (b) cell block (H&E stain, high magniﬁcation). (c) Encapsulated yeast stain
positive with mucicarmine stain (high magniﬁcation)and (d) result in a clear halo with an India ink preparation (high magniﬁcation).
estimated that 5–10% of HIV patients will develop NHL,
including Burkitt lymphoma, plasmablastic lymphoma
(PBL), primary eﬀusion lymphoma (PEL), and HHV8-
associated lymphoma arising from multicentric Castleman’s
disease. These are all aggressive, high-grade lymphomas
that usually manifest with extranodal involvement [77].
Burkitt lymphoma accounts for 30% of all HIV-associated
lymphomas, and EBV is positive in a subset of these
malignancies. Diﬀuse large B-cell lymphomas, particularly
the immunoblastic variant, can also be associated with EBV
in HIV-positive patients. With the use of ancillary studies,
such as ﬂow cytometry, immunocytochemistry on cell block
material, and FISH studies (e.g., for myc activation) on
unstained slides prepared at the time of aspiration, the
diagnosis of lymphoma can readily be made by FNA.
PBL, initially described involving mainly the jaw and
oral cavity of HIV-positive patients, has since been reported
within lymph nodes and many diﬀerent extranodal sites.
Two subtypes of PBL have been described: (i) oral mucosa
type and (ii) PBL with plasmacytic diﬀerentiation. Although
this is a B-cell lymphoma, plasmablasts may be negative
for CD45 (LCA) and the B-cell markers CD20 and PAX 5.
However, these tumor cells are positive for CD79a, plasma
cell antigens (CD138, CD38, and MUM-1), as well as CD56,
CD30,and EMA. PBL is also closely associated with EBV [9],
and,likeBurkitt’slymphoma,mayhavestructuralalterations
of the MYC locus. PEL, which represents only around 4%
of AIDS-related lymphomas, is associated with HHV-8 and
arises mainly with late-stage AIDS. Two subtypes of PEL are
described: (1) classic PEL presents with eﬀusions in pleural,
peritoneal, and pericardial cavities, and (ii) solid PEL, which
involves extracavitary tissue and may manifest with an
eﬀusion in addition to nodal or solid tissue lymphoma.
The cytology of either PEL subtype is characterized by
large atypical lymphoid cells ranging in appearance from
immunoblastic to anaplastic phenotype (Figure 6)[ 78]. In
the majority of cases, PEL cells lack B- and T-cell markers,
but coexpress CD30, EMA, plasma cell antigens (CD38,
CD138, and MUM-1), and HHV-8 [78]. PEL, like many
of the other aggressive AIDS-related NHL, portends a poor
prognosis [79]. Plasma cell neoplasia needs to be considered
inlymphomawithplasmacelldiﬀerentiationinthesettingof
HIV infection. HIV-positive patients are at increased risk of
developingplasma cell neoplasia [80] ata muchyoungerage,
with more aggressive disease and often multiple plasma cell
tumors in unusual locations. The cytomorphologyof plasma6 Pathology Research International
(a) (b)
Figure 6: Atypical lymphoid cells in a case of primary eﬀusion lymphoma of the pleura. (a) Pap stain (high magniﬁcation)and (b) Wright-
Giemsa stain (high magniﬁcation).
cell tumors in HIV-infected persons often shows anaplastic
features (Figure 7).
7.PulmonaryDisease
The lung is a rich niche for opportunistic infections, and,
for that reason, respiratory samples from HIV patients are
frequently examined. With HAART therapy, pneumocystis
continues to be a major opportunistic pulmonary pathogen
as well as extrapulmonary manifestations, such as the liver,
spleen, skin, and pleural eﬀusion in HIV-positive patients. A
speciﬁc diagnosis of pneumocystis requires demonstration of
organisms in respiratory specimens, and BAL is favored over
inducedsputumforpneumocystisinvestigation [81].Sputum
oﬀersa speciﬁcity of nearly 100%and sensitivity of55% [82]
while BAL alone has a diagnostic yield of 97–100% [83].
In general, a more invasive procedure (e.g., BAL) used to
collect specimens will provide better diagnostic yield. BAL
and/or biopsy is preferable in diﬃcult clinical settings, for
example an uncooperative patient, a patient too dyspneic. In
a patient with altered mental status, endotracheal aspirates
can be submitted for pneumocystis investigation. The typical
cytology ﬁnding shows foamy casts containing round or
crescent cysts measuring 5–8 microns, with sporozoites
located within these cysts. Numerous collapsed cysts may
appeartobe“budding,”andrarelyagranulomatousresponse
maybeseen.Immunoﬂuorescentstainingwithamonoclonal
antibody directed against the pneumocystis cell wall of both
cysts and trophozoites may increase the diagnostic yield in
these cases [84], but this is not speciﬁc for pneumocystis
[85]. Today, medical prophylaxis causes fewer organisms
resulting in higher false-negative diagnoses for pneumocystis
with cytology specimens [83].
Histoplasma capsulatum causes pneumonia in HIV-
positive patients resulting in a cavitary lesion, and lung
mass that mimics malignancy or disseminated disease.
H. capsulatum yeast forms (2–5µmi nd i a m e t e r )r e s i d e
within macrophages (Figure 8), and will stain positively
with Periodic acid-Schiﬀ (PAS) and Gomori methenamine
silver (GMS) stains. Mycobacterial infection of the lung
in respiratory samples may be heralded by the ﬁnding
of granulomatous inﬂammation with or without caseation
[86]. A combination of an acid fast stain (e.g., Ziehl-
Neelsen, Kinyoun,or auramine-rhodamine stains) with PCR
in one study showed a sensitivity of 84% and a speciﬁcity
of 100% [87]. Cytomegalovirus (CMV) is rarely found as
a primary pulmonary pathogen in HIV-positive patients
[88], in comparison to lung transplant recipients [89].
CMV is readily identiﬁable by viral inclusions in cytologic
material obtained by BAL, and, if necessary, conﬁrmed using
immunocytochemistry [90].
Pleuraleﬀusionsarecommonlyexaminedcytologicspec-
imen in HIV-positive patients, and the prevalence among
hospitalized AIDS patients is around 2–20% [91]. Common
ﬁndings in this setting include inﬂammatory pleural exu-
dates associated with a parapneumonic eﬀusion, empyema,
a lymphocytic exudate associated with mycobacterial infec-
tion, or malignancy due to lymphoma or metastatic carci-
noma.Otherrareretiologiesincludevolumeoverload,“crack
cocaine abuse” which results in anthracotic pigmentation
withineﬀusion macrophages[92]andan idiopathicetiology.
Bilateral pleural eﬀusions appear to be more common in
KS and lymphoma than in parapneumonic eﬀusion [93].
KS may result in either a chylous eﬀusion due to lymphatic
obstruction or a bloody eﬀusion with direct pleural disease.
KS cells within pleural ﬂuid tend to round up and take on an
ameboid appearance, sometimes with erythrophagocytosis.
AIDS-related lymphomas involving pleural eﬀusions may
be primary (i.e., PEL, referred to above) or secondary (i.e.,
disseminated systemic lymphoma).
8.GastrointestinalDisease
Common gastrointestinal (GI) malignancies encounter in
the HIV-positive patients include KS (60%), NHL (35%)
[94], and anal neoplasia. KS has been reported to occur
throughout the GI tract [94]. Involvement of the oral
cavity by KS could be seen in 10–50% of cases [95, 96],Pathology Research International 7
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Figure 7: Anaplastic plasmacytoma of the pelvic bone showingatypical plasma cells with (a) Pap stain (highmagniﬁcation),(b) Diﬀ Quick
stains (high magniﬁcation), and (c) in the cell block (H&E stain, high magniﬁcation). (d) Atypical plasma cells are immunoreactive with
CD138 stain (high magniﬁcation).
and up to 75% of HIV patients with oral KS likely have
concomitant GI lesions, frequently of their upper GI tract
[97]. The GI system represents the second most common
extranodal site for NHL, especially the anorectum [98]. The
majority of these lymphomas are high-grade B-cell NHL
that present with advanced tumor stage and life-threatening
complications, such as ulcers, bleeding, bowel obstruction,
and intussusception [99]. Low-grade MALT lymphoma of
stomach is rare in HIV patients [100]. Nonneoplastic GI
disease can accompany malignancy cases in HIV-positive
patients. For example, CMV infection can cause GI perfora-
tion, obstruction, and pseudotumor formation [101]. Other
infections also include cryptosporidiosis, microsporidiosis,
Giardia, atypical mycobacteria, and amebiasis. When dealing
with liver samples, viral hepatitis along with HIV can result
in accelerated progression to hepatocellular carcinoma, with
only a short interval between viral exposure and carcinoma
development [102].
9.Headand NeckPathology
HIV predisposes infected individuals to a broad spectrum of
head and neck diseases. Due to a high density of lymphoid
tissue, there is an increased risk of lymphoma in this
region ranging from low-grade NHL (e.g., MALT lymphoma
arising in the parotid gland) to aggressive NHL, such as
plasmablastic lymphoma of the jaw. SCC is the third most
common head and neck malignancy in HIV patients, after8 Pathology Research International
Figure 8: Bronchoalveolar lavage with histoplasma organisms
(arrows) present within macrophages (ThinPrep, Pap stain, high
magniﬁcation).
Figure 9: CSF showing cryptococcal yeast without inﬂammatory
response (Pap stain, high magniﬁcation).
KSand NHL[103].SynergybetweenHIVandHPVincreases
the prevalence of oropharyngeal cancer, especially tonsillar
cancer [104]. The cytologic diagnosis of SCC is relatively
straightforward, and p16 immunoreactivity of tumor cells
may prove helpful in some cases. A unique feature is the
presence of multinucleated tumor giant cells found in up to
98% of cases with HIV-associated SCC [105].
Benign oral ulcers and lesions may be attributed to
infection such as herpes. Tzank smears can be used to render
a rapid diagnosis, and it involves scrapping of an ulcer
base to look for herpetic changes. The parotid gland in
HIV-positive patients often contains bilateral cystic lesions
referred to as benign lymphoepithelial cysts (BLEC). BLEC
presents as painless swelling of the parotid, and cysts often
recur after successful aspiration. FNA from these cysts
yields clear to yellow-brown watery ﬂuid, and cytologic
ﬁndings comprise of admixed anucleated, superﬁcial and
intermediate squamous cells with lymphocytes, and tingible
body macrophages [106]. Other disease entities arising
within salivary glands in HIV-positive patients are low-risk
lymphoma arising in BLEC, intraparotid lymphadenopathy,
diﬀuse inﬁltrative lymphocytosis syndrome, and sialadenitis
secondary to unusual infections, such as cytomegalovirus
[107, 108] and cryptococcus [109]. Eventhe thyroid gland in
HIV patients can rarely be involved by CMV infection [110]
and pneumocystis [111].
10.Neuropathology
HIV can aﬀect the central (CNS) and peripheral nervous
system by primary eﬀect (e.g., HIV encephalopathy or
polyneuropathy) or as a result of opportunistic infections or
neoplasms. Benign lymphocytosis of the CSF is frequently
encountered at the time of primary HIV infection [77],
but other possible etiologies include viral encephalitis,
infectious meningitis (e.g., tuberculosis and toxoplasmosis),
neurosyphilis, and progressive multifocal leukoencephalopa-
thy (PML). CSF is routinely examined in AIDS patients
presenting with neurologicalsymptoms fortheidentiﬁcation
of fungi, parasites, and lymphoma. Cryptococcal meningitis
rarely causes a host inﬂammatory response, and yeast may
range in number from very few to overwhelming numbers
of organisms. Typical Cryptococcus neoformans in CSF are
round (5–15 micrometer) with a thick refractile capsule and
narrow based budding (Figure 9). Special stains used to
identify encapsulated forms include an India ink prepara-
t i o n ,G M S,P A S,a n dF o n t a n a - M a s s o ns t a i n s .R a r e l y ,p a t i e n t s
may have capsule-deﬁcient cryptococci that may be easily
mistaken for other microorganisms (e.g., histoplasmosis).
Of note, CMV inclusions and Toxoplasma gondii are rarely
seen in CSF [77]. However, Toxoplasma gondii may be
observed in brain smears or touch preparation performed
for an intracranial mass lesion. Deﬁnitive diagnosis in a
brain smear requires identiﬁcation of “bags of parasites”
(i.e., cells infected with multiple bradyzoites) and smears
usually also contain reactive astrocytes, mixed inﬂammatory
cells, and background dirty necrosis. With HAART ther-
apy, primary CNS lymphoma is infrequently encountered.
These lymphomas are always high-grade B-cell lymphomas
(Figure 10) that are strongly associated with EBV. They
occur with advanced AIDS disease, and patients have a
poor prognosis. A typical CSF specimen containing CNS
lymphoma is usually highly cellular with large malignant
cells showing prominent immunoblastic nucleoli. In some
cases, detection of EBV in CSF may support the diagnosis
of CNS lymphoma.
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